“…The major activities of EGCG include inhibition of numerous signaling pathways and protein kinases (AP-1, p44/p42 MAPK, Erk1/2, EGF-R, PDGF-R, FGF-R), inhibition of cell proliferation, induction of apoptosis, modulation of cell cycle regulation, interference with receptor binding and suppression of invasiveness and angiogenesis [17,18]. Recently, some studies showed that EGCG could inhibit the invasion and migration of human oral cancer cells through multiple mechanisms, possibly by the decreased production of MMP (matrix metalloproteinase)-2, MMP-9 and uPA or the demethylation effect on MMP inhibitors, such as RECK [19,20]. Also, EGCG has been reported to inhibit ligandinduced c-Met phosphorylation and potentially block invasive cancer growth [4,21].…”